REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jaspharm CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jaspharm CIA Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Jaspharm CIA Ltda is based in Ecuador. The head office is in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on July 03, 2012. The total number of employees is currently 202 (2023). There was a net sales revenue drop of 1.51% reported in Jaspharm CIA Ltda’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 11.38%. The net profit margin of Jaspharm CIA Ltda increased by 0.04% in 2023.

Headquarters
Republica Oe8-26
Quito; Pichincha;

Contact Details: Purchase the Jaspharm CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Jaspharm CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Jaspharm CIA Ltda report to view the information.
Registered Capital:
Purchase the Jaspharm CIA Ltda report to view the information.
Incorporation Date:
July 03, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
33.68%
Purchase this report to view the information.
33.16%
Purchase this report to view the information.
33.16%
Company Performance
Financial values in the chart are available after Jaspharm CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.51%▼
Total operating revenue
-1.69%▼
Operating profit (EBIT)
-87.83%▼
EBITDA
-86.46%▼
Net Profit (Loss) for the Period
0.34%▲
Total assets
-11.38%▼
Total equity
4.59%▲
Operating Profit Margin (ROS)
-55.52%▼
Net Profit Margin
0.04%▲
Return on Equity (ROE)
-0.32%▼
Debt to Equity Ratio
-70.04%▼
Quick Ratio
0.1%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo